127 related articles for article (PubMed ID: 23236666)
1. ["Off label" use of some medicinal products. Part II. "Off label" use of misoprostol].
Sirakov M
Akush Ginekol (Sofiia); 2012; 51(3):50-4. PubMed ID: 23236666
[TBL] [Abstract][Full Text] [Related]
2. [Misoprostol off label essential for women's health].
Danielsson KG
Lakartidningen; 2013 Nov 13-19; 110(46):2045-6. PubMed ID: 24380157
[No Abstract] [Full Text] [Related]
3. Misoprostol: a quarter century of use, abuse, and creative misuse.
Chong YS; Su LL; Arulkumaran S
Obstet Gynecol Surv; 2004 Feb; 59(2):128-40. PubMed ID: 14752301
[TBL] [Abstract][Full Text] [Related]
4. [Status and expertise of off-label use of misoprostol in obstetrics and gynecology in France: study by CNGOF (short text)].
Marret H; Simon E; Beucher G; Dreyfus M; Gaudineau A; Vayssière C; Lesavre M; Pluchon M; Winer N; Fernandez H; Aubert J; Bejan-Angoulvant T; Jonville-Bera AP; Clouqueur E; Houfflin-Debarge V; Garrigue A; Pierre F;
J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):107-13. PubMed ID: 24438770
[No Abstract] [Full Text] [Related]
5. Off-label use of misoprostol for labor induction: a nation-wide survey in Switzerland.
Krause E; Malorgio S; Kuhn A; Schmid C; Baumann M; Surbek D
Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):324-8. PubMed ID: 21958953
[TBL] [Abstract][Full Text] [Related]
6. [Off-label use of misoprostol in obstetrics and gynecology: methods and organization].
Simon EG; Fritel X
J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):103-6. PubMed ID: 24440127
[No Abstract] [Full Text] [Related]
7. Use of misoprostol (prostaglandin E1 methyl analogue) to expedite delivery in severe preeclampsia remote from term.
Del Valle GO; Sanchez-Ramos L; Jordan CW; Gaudier FL; Delke I
J Matern Fetal Med; 1996; 5(1):39-40. PubMed ID: 8796765
[TBL] [Abstract][Full Text] [Related]
8. Use of misoprostol in pregnancy.
Hale RW; Zinberg S
N Engl J Med; 2001 Jan; 344(1):59-60. PubMed ID: 11136964
[No Abstract] [Full Text] [Related]
9. [Misoprostol--a new prostaglandin in obstetrical practice].
Katsulov A; Todorova Ts
Akush Ginekol (Sofiia); 1998; 37(2):59-66. PubMed ID: 9859543
[No Abstract] [Full Text] [Related]
10. The use of misoprostol in termination of second-trimester pregnancy.
Lin CJ; Chien SC; Chen CP
Taiwan J Obstet Gynecol; 2011 Sep; 50(3):275-82. PubMed ID: 22030039
[TBL] [Abstract][Full Text] [Related]
11. WHO recommendations for misoprostol use for obstetric and gynecologic indications.
Tang J; Kapp N; Dragoman M; de Souza JP
Int J Gynaecol Obstet; 2013 May; 121(2):186-9. PubMed ID: 23433680
[TBL] [Abstract][Full Text] [Related]
12. [Misoprostol in gynecology and obstetrics].
Halmesmäki E; Nuutila M
Duodecim; 1998; 114(14):1422-4. PubMed ID: 11552252
[No Abstract] [Full Text] [Related]
13. Randomized comparison of 3 misoprostol protocols for abortion induction at 13-20 weeks of gestation.
Caliskan E; Dilbaz S; Doger E; Ozeren S; Dilbaz B
J Reprod Med; 2005 Mar; 50(3):173-80. PubMed ID: 15841929
[TBL] [Abstract][Full Text] [Related]
14. Use of misoprostol in obstetrics and gynecology.
Song J
Obstet Gynecol Surv; 2000 Aug; 55(8):503-10. PubMed ID: 10945193
[TBL] [Abstract][Full Text] [Related]
15. The pharmacokinetics and different regimens of misoprostol in early first-trimester medical abortion.
Tang OS; Ho PC
Contraception; 2006 Jul; 74(1):26-30. PubMed ID: 16781256
[TBL] [Abstract][Full Text] [Related]
16. Early termination of pregnancy by single-dose 800 microg misoprostol compared with surgical evacuation.
Prasad S; Kumar A; Divya A
Fertil Steril; 2009 Jan; 91(1):28-31. PubMed ID: 18295212
[TBL] [Abstract][Full Text] [Related]
17. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
Hamoda H; Ashok PW; Flett GM; Templeton A
BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
[TBL] [Abstract][Full Text] [Related]
18. Association of intravenous oxytocin to vaginal misoprostol for mid trimester labor induction.
Hidar S; Jerbi M; Khaïri H
Am J Obstet Gynecol; 2006 Jul; 195(1):332-3; author reply 333-4. PubMed ID: 16813766
[No Abstract] [Full Text] [Related]
19. Is misoprostol a safe, effective and acceptable alternative to manual vacuum aspiration for postabortion care? Results from a randomised trial in Burkina Faso, West Africa.
Dao B; Blum J; Thieba B; Raghavan S; Ouedraego M; Lankoande J; Winikoff B
BJOG; 2007 Nov; 114(11):1368-75. PubMed ID: 17803715
[TBL] [Abstract][Full Text] [Related]
20. [Conflicting recommendations between the French national authority for health (HAS) and clinical practice guidelines (CNGOF); focus on 200 late medical abortions, conducted outside marketing authorizations].
Bréard H; Pressat Laffouilhere T; Braund S; Duhamel O; Réal-Lhommet A; Machevin E
Gynecol Obstet Fertil Senol; 2019 Dec; 47(12):854-859. PubMed ID: 31626980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
